Panacea Biotec Limited announced the appointment of Ambika Sharma to its Board of Directors, with effect from February 14, 2024.
According to the company’s exchange filing, “the Board of Directors of Panacea Biotec Limited (“the Company”) has, at its meeting held today, i.e. February 13, 2024, inter-alia considered and approved the appointment of Mrs. Ambika Sharma (DIN: 08201798) as an additional director in the capacity of Independent Director based on the recommendation of the Nomination and Remuneration Committee of the Company, for a term of 5 (five) consecutive years with effect from February 14, 2024, subject to the approval of the shareholders of the Company through postal ballot.”
Ambika Sharma aged about 61 years, is a holder of Bachelor’s degree in Economics and Master’s degree in Business Economics from India’s prestigious Delhi University and has 37 years of diverse experience.
Ambika Sharma was the first lady Director General – International at the Federation of Indian Chambers of Commerce and Industry (FICCI). She went on to lead the U.S. Chamber’s U.S.-India Business Council (USIBC) as Managing Director, India. She joined USIBC in 2018, making it one of the most sought-after names as a policy advocacy organization in U.S.-India business relations. She has now moved into a strategic role as Advisor to the US-India Strategic Partnership Forum USISPF.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.